trending Market Intelligence /marketintelligence/en/news-insights/trending/Qcd7omv-wyRO4IcAT_idgQ2 content esgSubNav
In This List

Novartis Oncology CEO to retire

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Novartis Oncology CEO to retire

Novartis AG said Novartis Oncology CEO Bruno Strigini will retire for personal reasons.

He will step back from Novartis' executive committee by Dec. 31 and fully hand over in early 2018, the company said in a news release.

Strigini joined Novartis in 2014 as president of oncology and became CEO of the unit in July 2016. He previously served as Merck & Co. Inc.'s president for Europe and Canada.